Recent data from insurance claims indicates that 30% of patients stop treatment within a month, well before any clinically meaningful results could be achieved
SURMOUNT-1 published in the New England Journal of Medicine in July 2022, showing 22.5% weight loss at 72 weeks (Jastreboff et al., NEJM 2022)
and suicidal ideation or behavior (particularly with Wegovy)
The GLP-1 Pro formula provides an unmatched, comprehensive blend of key probiotics, prebiotics, and herbs to support appetite control and curb food cravings
The table below shows example preparations vial size, an example water volume, and the resulting concentration
Staying Ahead of the Change The companies and brands that innovate in anticipation of the impact of these drugs will find themselves awash in new interest from those who feel a new sense of control and autonomy in their choices: brands that speak to their aspirational selves, affirm their commitments to living better, and underscore that behavior-modifying medications are only step one of a lifelong shift that includes their category and brand
